Krystal Biotech, Inc. (($KRYS)) announced an update on their ongoing clinical study. Krystal Biotech, Inc. is conducting a Phase 1 clinical study ...
After the FDA revoked Sarepta Therapeutics’ platform designation in July, Krystal Biotech is “poised to be the first major beneficiary” of this program, according to analysts at William Blair. The FDA ...
When former Spice Girl Mel B revealed that she was temporarily blinded in one eye due to a herpes-related complication, it shocked many fans and sparked a wave of questions about the virus’s potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback